Evaluation of Camptothecin Through Computational and Experimental Approaches Targeting Membrane Receptors on Breast Cancer Cells for Potential Therapeutic Applications
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177857 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Elmer Joel Millan-Casarrubias und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Mexico City 07340, Mexico. Hauptthemen laut MEDLINE: Camptothecin, Breast Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Politécnico Nacional.
Abstract (Originalsprache)
Breast cancer remains among the leading causes of incidence and mortality worldwide. Consequently, identifying new treatments and strategies is of critical importance. Evidence indicates that camptothecin and its derivatives may exert anticancer effects in various cancer cell lines, including colon, lung, and ovarian cancers. However, their effects in breast cancer are not yet fully understood. Prior theoretical studies employing docking and molecular dynamics suggest that camptothecin could bind to the HER2 and EGFR receptors, which are overexpressed in breast cancer cells. Investigating interactions between novel molecules with affinity for membrane receptors overexpressed in breast cancer is important for developing personalized therapies and for advancing strategies to selectively target nanomaterials to these cells for diagnostic and therapeutic purposes. This study evaluated the in silico and in vitro effects of camptothecin on the MCF-7 and MDA-MB-231 breast cancer cell lines. Our results show significant inhibition of proliferation and reduced migration at 24, 48, and 72 h in both cell lines. The theoretical analysis indicates high affinity of camptothecin for receptors overexpressed in breast cancer compared with current treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Mexico City 07340, Mexico.
- Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City 07360, Mexico.
ORCID-Profile: Elmer Joel Millan-Casarrubias, Lucero Ruiz-Mazón, Oscar Eduardo Cigarroa-Mayorga
Förderung
- Instituto Politécnico Nacional
Zitieren
APA
Millan-Casarrubias, E. J., Ruiz-Mazón, L., Pérez Salazar, E., Cortés Reynosa, P., Hernández-Rodríguez, Y. M., & Cigarroa-Mayorga, O. E. (2026). Evaluation of Camptothecin Through Computational and Experimental Approaches Targeting Membrane Receptors on Breast Cancer Cells for Potential Therapeutic Applications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177857
Vancouver
Millan-Casarrubias EJ, Ruiz-Mazón L, Pérez Salazar E, Cortés Reynosa P, Hernández-Rodríguez YM, Cigarroa-Mayorga OE. Evaluation of Camptothecin Through Computational and Experimental Approaches Targeting Membrane Receptors on Breast Cancer Cells for Potential Therapeutic Applications. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177857
BibTeX
@article{MillanCasarrubias2026,
author = {Millan-Casarrubias, Elmer Joel and Ruiz-Mazón, Lucero and Pérez Salazar, Eduardo and Cortés Reynosa, Pedro and Hernández-Rodríguez, Yazmín Mariela and Cigarroa-Mayorga, Oscar Eduardo},
title = {Evaluation of Camptothecin Through Computational and Experimental Approaches Targeting Membrane Receptors on Breast Cancer Cells for Potential Therapeutic Applications},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177857}
}
EUVIMED